| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234066 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
The study showed the feasibility of irradiation with RSR combined with chemotherapy and surgery for breast tumors. There was no skin toxicity at a dose of 19.5 Gy or 22.5 Gy delivered in three fractions combined with chemotherapy. Lack of toxicity suggested that the dose could be increased further. Pathologic response was acceptable.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pierre-Yves M.D., Ph.D., Phillipe M.D., Ph.D., Michel M.D., Isabelle M.D., Claire M.D., Emmanuel M.D., Adel M.D., Catherine M.D., Juliette M.D., Jean-Marc M.D.,